More Articles


Making the Patient-Centric Trial a Reality

Danielle Barron, (Dec 14, 2016)

Learn what a panel of experts had to say on how we can create value for patients in trials, keep them engaged, and treat them like gold.
Market Access

Mind the Gap

Adam Hill, (Dec 13, 2016)

The importance of real-world evidence in market access is growing, but what rules can pharma follow to close the evidence gaps?

Surviving the Tidal Wave

Dr Nicola Davies, (Dec 8, 2016)

Pharma needs new strategies in the face of a 'tidal wave' of costly and complex diseases.

Made to Measure

Danielle Barron, (Dec 7, 2016)

Pharma needs to measure the patient-centricity of its clinical trials as accurately as any other variable, says Professor Michael Howley

Engagement with Impact

Deirdre Coleman, (Dec 5, 2016)

Medical Science Liasions need more than just scientific acumen to get the message across.

Engaging Kids to Fight Malaria

Thomas Disley, (Dec 1, 2016)

An interview with the team behind the MOSKI KIT, a Sanofi tool against malaria.

The End of Paper?

Danielle Barron, (Nov 30, 2016)

Paperless clinical trials have gained momentum but what barriers need to be cleared before we say goodbye to paper forever?

Architects of Value

Deirdre Coleman, (Nov 28, 2016)

Dr Ameet Nathwani, Chief Medical Officer at Sanofi, discusses the vital role Medical Affairs is playing in using data to demonstrate value

Pavlov Had a Point

Paul Harney, (Nov 25, 2016)

How can we help patients to overcome the emotional barriers to taking their medicines?

The Changing Face of Medical Affairs

Deirdre Coleman, (Nov 22, 2016)

MA is set to become a fully-fledged strategic partner. But what has driven this change & what can we expect in years to come?